Current Market Outlook

Kalshi traders see only a 39% chance that 10 or more AIPAC-endorsed candidates will lose their primary elections between April and September 2026. That means the market thinks it's more likely than not that AIPAC's endorsed slate will survive primary challenges at a rate of 90% or better. But 39% is not a fringe bet. It says a meaningful minority of traders see real risk of a primary bloodbath for the pro-Israel lobbying group's chosen candidates.

Key Factors Driving the Odds

AIPAC's PAC endorses a broad mix of incumbents and open-seat contenders. In 2024, only a handful of endorsed candidates lost primaries, mostly in safe Democratic seats where challengers ran on Gaza-related anger. But the 2026 cycle is different. The Israel-Hamas war continues to polarize the Democratic base, and progressive groups like Justice Democrats and the Working Families Party have explicitly targeted AIPAC-backed incumbents in blue districts.

The 39% probability reflects two competing realities. First, AIPAC has massive financial firepower. In 2024, its super PAC spent over $100 million, mostly to protect incumbents. Second, the number of truly competitive primaries for AIPAC-endorsed candidates is small. Most endorsed candidates run in safe seats where a primary loss is unlikely. The market is saying that even with heightened activism, the structural odds favor AIPAC.

What Could Change These Odds

The key date is the candidate filing deadline, which varies by state but mostly falls in late 2025 or early 2026. If a wave of credible progressive challengers announces against AIPAC-backed incumbents in districts like NY-16 (Bowman's old seat) or MI-12 (Tlaib's seat, though she is not AIPAC-endorsed), the probability could jump toward 50% or higher.

Another catalyst: a major escalation in Gaza or a new Israeli government policy that inflames Democratic voters. If anger peaks right before primary season, the number of close races could multiply. Conversely, if the war de-escalates or AIPAC successfully recruits moderate challengers to primary its own critics, the 39% number could drift lower. The market is pricing in a real but contained risk.